Budget 2022 impact on pharma & healthcare

The Budget speech identified ‘Genomics and Pharmaceuticals’ to be among the sunrise opportunities eligible for supportive policies, light-touch regulations, facilitative actions to build domestic capacities and promotion of R&D. The government will promote thematic funds for blended finance with the government share being limited to 20% and the funds being managed by private fund managers.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/TNyBXSdsk
via IFTTT